+1 (904) 942-2327
$99.00 – $950.40Price range: $99.00 through $950.40
Mazdutide is an investigational synthetic peptide supplied exclusively for laboratory and in-vitro research involving incretin receptor signaling pathways. It is referenced in scientific literature for studies examining GLP-1 and GIP receptor interactions, intracellular signaling activity, and metabolic pathway behavior in controlled experimental systems.
Ingredients / Composition:
Active Compound: Mazdutide (synthetic dual-agonist peptide)
Net Peptide Content: 5 mg per vial
Form: Lyophilized peptide powder
Excipients: None added unless otherwise stated
Research applications may include evaluation of ligand–receptor binding characteristics, signal transduction mechanisms associated with incretin pathways, and cellular metabolic response modeling. All references to concentrations and published studies are provided strictly for scientific background and experimental design purposes only.
This compound is not approved for human or veterinary use and is not intended for diagnostic or therapeutic applications.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Mazdutide is an investigational dual-agonist peptide developed for scientific research involving incretin receptor signaling pathways. This compound is supplied exclusively for in-vitro and laboratory-based experimental applications and is not approved for human or veterinary use.
Mazdutide has been studied for its interaction with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, making it a valuable tool for researchers exploring metabolic signaling networks, ligand-receptor binding dynamics, and downstream cellular response mechanisms. Its dual-receptor activity allows investigators to evaluate coordinated pathway activation within controlled experimental environments.
Mazdutide may be utilized in a variety of laboratory research settings, including but not limited to:
Receptor binding and affinity assays
Signal transduction pathway analysis
Incretin-related cellular response studies
Comparative peptide structure-function research
Pharmacodynamic and stability evaluations in experimental models
Researchers may incorporate this compound into controlled protocols to observe receptor activation patterns, intracellular signaling cascades, and metabolic pathway modulation under defined laboratory conditions.
Each vial contains 5 mg of lyophilized Mazdutide, prepared for accurate measurement and reproducible experimental use. Analytical verification methods such as HPLC and mass spectrometry are used where applicable to confirm compound identity and purity. This supports consistency across experimental runs and long-term research projects.
For optimal integrity, standard laboratory cold-storage conditions are recommended. Proper reconstitution, aliquoting, and storage procedures should follow institutional laboratory protocols and compound-handling best practices.
This product is intended solely for scientific research purposes. It is not intended for:
Human consumption
Animal use
Diagnostic applications
Therapeutic development or clinical administration
No physiological outcomes, health effects, or performance results are implied or guaranteed. Purchasers are responsible for ensuring that all use complies with applicable laboratory regulations, institutional review standards, and local regulatory requirements.
Mazdutide is provided as an Antagonist only, supporting controlled scientific investigation into incretin receptor mechanisms and metabolic pathway signaling.
Mazdutide is an investigational synthetic peptide supplied exclusively for laboratory and in-vitro research involving incretin receptor signaling pathways. It is referenced in scientific literature for studies examining GLP-1 and GIP receptor interactions, intracellular signaling activity, and metabolic pathway behavior in controlled experimental systems.
Ingredients / Composition:
Active Compound: Mazdutide (synthetic dual-agonist peptide)
Net Peptide Content: 5 mg per vial
Form: Lyophilized peptide powder
Excipients: None added unless otherwise stated
Research applications may include evaluation of ligand–receptor binding characteristics, signal transduction mechanisms associated with incretin pathways, and cellular metabolic response modeling. All references to concentrations and published studies are provided strictly for scientific background and experimental design purposes only.
This compound is not approved for human or veterinary use and is not intended for diagnostic or therapeutic applications.
Mazdutide is an investigational dual-agonist peptide developed for scientific research involving incretin receptor signaling pathways. This compound is supplied exclusively for in-vitro and laboratory-based experimental applications and is not approved for human or veterinary use.
Mazdutide has been studied for its interaction with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, making it a valuable tool for researchers exploring metabolic signaling networks, ligand-receptor binding dynamics, and downstream cellular response mechanisms. Its dual-receptor activity allows investigators to evaluate coordinated pathway activation within controlled experimental environments.
Mazdutide may be utilized in a variety of laboratory research settings, including but not limited to:
Receptor binding and affinity assays
Signal transduction pathway analysis
Incretin-related cellular response studies
Comparative peptide structure-function research
Pharmacodynamic and stability evaluations in experimental models
Researchers may incorporate this compound into controlled protocols to observe receptor activation patterns, intracellular signaling cascades, and metabolic pathway modulation under defined laboratory conditions.
Each vial contains 5 mg of lyophilized Mazdutide, prepared for accurate measurement and reproducible experimental use. Analytical verification methods such as HPLC and mass spectrometry are used where applicable to confirm compound identity and purity. This supports consistency across experimental runs and long-term research projects.
For optimal integrity, standard laboratory cold-storage conditions are recommended. Proper reconstitution, aliquoting, and storage procedures should follow institutional laboratory protocols and compound-handling best practices.
This product is intended solely for scientific research purposes. It is not intended for:
Human consumption
Animal use
Diagnostic applications
Therapeutic development or clinical administration
No physiological outcomes, health effects, or performance results are implied or guaranteed. Purchasers are responsible for ensuring that all use complies with applicable laboratory regulations, institutional review standards, and local regulatory requirements.
Mazdutide is provided as an Antagonist only, supporting controlled scientific investigation into incretin receptor mechanisms and metabolic pathway signaling.
Mazdutide is an investigational synthetic peptide supplied exclusively for laboratory and in-vitro research involving incretin receptor signaling pathways. It is referenced in scientific literature for studies examining GLP-1 and GIP receptor interactions, intracellular signaling activity, and metabolic pathway behavior in controlled experimental systems.
Ingredients / Composition:
Active Compound: Mazdutide (synthetic dual-agonist peptide)
Net Peptide Content: 5 mg per vial
Form: Lyophilized peptide powder
Excipients: None added unless otherwise stated
Research applications may include evaluation of ligand–receptor binding characteristics, signal transduction mechanisms associated with incretin pathways, and cellular metabolic response modeling. All references to concentrations and published studies are provided strictly for scientific background and experimental design purposes only.
This compound is not approved for human or veterinary use and is not intended for diagnostic or therapeutic applications.
WhatsApp us
Reviews
There are no reviews yet.